ULURU Inc. Eliminates Remaining Debt From The Balance Sheet - Convertible Debt Retired for Common Stock -

ADDISON, Texas, July 31, 2014 /PRNewswire/ -- ULURU Inc. (OTCQB: ULUR), today announced the retirement of the two convertible notes. With the retirement of these convertible notes, the Company currently has no outstanding debt on its balance sheet.

The two Convertible Notes totalling $265,000 were issued in June and July 2011 to Kerry P. Gray, President and CEO of ULURU Inc. In accordance with the terms of the convertible notes, Mr. Gray received 232,408 shares of common stock in exchange for the retirement of the debt.

About ULURU Inc.:
ULURU Inc. is a specialty pharmaceutical company focused on the development of a portfolio of wound management and oral care products to provide patients and consumers improved clinical outcomes through controlled delivery utilizing its innovative Nanoflex® Aggregate technology and OraDisc™ transmucosal delivery system.  For further information about ULURU Inc., please visit our website at www.ULURUinc.com.  For further information about Altrazeal®, please visit www.Altrazeal.com.

This press release contains certain statements that are forward-looking within the meaning of Section 27a of the Securities Act of 1933, as amended.  These statements are subject to numerous risks and uncertainties, including but not limited the risk factors detailed in the Company's Annual Report on Form 10-K for the year ended December 31, 2013, and other reports filed by us with the Securities and Exchange Commission.

Contact: Investor Relations

Contact: Company

Jim MacDonald

Kerry P. Gray

Torrey Hills Capital

President & CEO

(858) 456-7300

Terry K. Wallberg


Vice President & CFO

(214) 905-5145

SOURCE ULURU Inc.



RELATED LINKS
http://www.uluruinc.com

More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.